ASEP Medical Holdings Inc.
SEPSF
$0.39
-$0.21-35.50%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 212.70K | 213.30K | 217.20K | 179.30K | 124.50K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 212.70K | 213.30K | 217.20K | 179.30K | 124.50K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 212.70K | 213.30K | 217.20K | 179.30K | 124.50K |
| SG&A Expenses | 1.37M | 1.80M | 1.88M | 2.36M | 2.73M |
| Depreciation & Amortization | 720.30K | 832.40K | 951.20K | 960.80K | 964.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.14M | 2.70M | 2.89M | 3.40M | 3.92M |
| Operating Income | -1.92M | -2.49M | -2.67M | -3.22M | -3.79M |
| Income Before Tax | -9.52M | -9.64M | -9.86M | -4.05M | -4.56M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.52 | -9.64 | -9.86 | -4.05 | -4.56 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 3.73M | 3.80M | 3.89M | 642.30K | 714.70K |
| Net Income | -5.79M | -5.83M | -5.96M | -3.41M | -3.85M |
| EBIT | -1.92M | -2.49M | -2.67M | -3.22M | -3.79M |
| EBITDA | -1.21M | -1.66M | -1.72M | -2.28M | -2.84M |
| EPS Basic | -0.72 | -0.76 | -0.78 | -0.48 | -0.56 |
| Normalized Basic EPS | 0.31 | 0.27 | 0.26 | -0.23 | -0.28 |
| EPS Diluted | -0.72 | -0.76 | -0.78 | -0.48 | -0.56 |
| Normalized Diluted EPS | 0.31 | 0.27 | 0.26 | -0.23 | -0.28 |
| Average Basic Shares Outstanding | 34.39M | 31.11M | 30.41M | 29.40M | 28.12M |
| Average Diluted Shares Outstanding | 34.39M | 31.11M | 30.41M | 29.40M | 28.12M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |